Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Marrow Suppression”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Testing effectiveness (Phase 2)Enrolling By InvitationNCT06370416
What this trial is testing

The Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Who this might be right for
Non-small Cell Lung Cancer
Henan Cancer Hospital 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT03924401
What this trial is testing

Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant

Who this might be right for
Graft Versus Host Disease
Emory University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06589089
What this trial is testing

Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 18
Large-scale testing (Phase 3)Looking for participantsNCT03818334
What this trial is testing

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Bone Marrow Transplant ComplicationsGraft Versus Host DiseaseInfection Viral+2 more
Hospital Israelita Albert Einstein 50
Testing effectiveness (Phase 2)Study completedNCT00000691
What this trial is testing

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 156
Large-scale testing (Phase 3)Not Yet RecruitingNCT05780294
What this trial is testing

A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

Who this might be right for
Nasopharyngeal CarcinomaLeucogenChemotherapy+1 more
Sun Yat-sen University 132
Post-approval studies (Phase 4)UnknownNCT03793205
What this trial is testing

G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients

Who this might be right for
Gynecologic CancerMyelosuppression AdultFebrile Neutropenia+1 more
Lei Li 100
Post-approval studies (Phase 4)Looking for participantsNCT07477119
What this trial is testing

Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Who this might be right for
LinezolidTuberculosis Multi Drug Resistant ActiveTherapeutic Drug Monitoring (TDM)
Marco Schiuma 150
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Not applicableEnded earlyNCT02375334
What this trial is testing

Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy

Who this might be right for
Malignant GliomaMyelosuppression
Wake Forest University Health Sciences 18
Large-scale testing (Phase 3)UnknownNCT03740464
What this trial is testing

Long-acting G-CSF for Febrile Neutropenia

Who this might be right for
Epithelial Ovarian CancerColony Stimulating FactorsFebrile Neutropenia+3 more
Lei Li 556
Testing effectiveness (Phase 2)Study completedNCT04477616
What this trial is testing

Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 160
Post-approval studies (Phase 4)Study completedNCT05071703
What this trial is testing

Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Ended earlyNCT02991898
What this trial is testing

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more
Masonic Cancer Center, University of Minnesota 3
Not applicableUnknownNCT01193933
What this trial is testing

Multicenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive Treatment

Who this might be right for
Ph-negative Adult Acute Lymphoblastic Leukemia
National Research Center for Hematology, Russia 321
Not applicableStudy completedNCT03719118
What this trial is testing

Tailored Therapeutic Model According to the Expression of Genes in Inflammatory Bowel Disease Patients

Who this might be right for
Inflammatory Bowel Diseases
Yonsei University 215
Testing effectiveness (Phase 2)Looking for participantsNCT07205536
What this trial is testing

Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy

Who this might be right for
MyelosuppressionThoracic NeoplasmsChemoradiotherapy
Affiliated Hospital of Nantong University 30
Post-approval studies (Phase 4)Study completedNCT00969462
What this trial is testing

Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Meir Medical Center 18
Large-scale testing (Phase 3)Ended earlyNCT04607668
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

Who this might be right for
Colorectal Cancer MetastaticMyelosuppression-AdultChemotherapeutic Toxicity
G1 Therapeutics, Inc. 326
Not applicableStudy completedNCT01060410
What this trial is testing

Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment

Who this might be right for
Lupus Erythematosus, SystemicAdverse Effects
Sun Yat-sen University 222
Load More Results